GNE-495

CAS No. 1449277-10-4

GNE-495( GNE 495 | GNE495 )

Catalog No. M11931 CAS No. 1449277-10-4

A potent and highly selective, cell permeable MAP4K4 inhibitor with IC50 of 3.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 81 In Stock
10MG 141 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GNE-495
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and highly selective, cell permeable MAP4K4 inhibitor with IC50 of 3.7 nM.
  • Description
    A potent and highly selective, cell permeable MAP4K4 inhibitor with IC50 of 3.7 nM; exhibits adequate potency preventing migration of HUVEC cells in vitro (IC50=57 nM); has good PK and demonstrates in vivo efficacy in a retinal angiogenesis model .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GNE 495 | GNE495
  • Pathway
    MAPK/ERK Signaling
  • Target
    MAP4K
  • Recptor
    MAP4K
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1449277-10-4
  • Formula Weight
    405.4249
  • Molecular Formula
    C22H20FN5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mg/mL
  • SMILES
    O=C(C1=C2C=CC(C3=CC=CC(F)=C3)=NC2=C(N)N=C1)NC4CN(C(C5CC5)=O)C4
  • Chemical Name
    1,7-Naphthyridine-5-carboxamide, 8-amino-N-[1-(cyclopropylcarbonyl)-3-azetidinyl]-2-(3-fluorophenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ndubaku CO, et al. ACS Med Chem Lett. 2015 Jun 29;6(8):913-8.
molnova catalog
related products
  • MAP4K4-IN-37

    MAP4K4-IN-37 is a potent, selective, orally active inhibitor of serine-threonine kinase MAP4K4 with IC50 of 0.4 nM.

  • HG6-64-1

    HG6-64-1 is a potent dual TAK1 and MAP4K2 ((germinal center kinase, GCK)) inhibitor with IC50 of 41 nM and 98 nM, respectively.

  • MAP4K4-IN-17

    MAP4K4-IN-17 is a potent and highly selective MAP4K4 inhibitor with IC50 of 14.9 nM.